DNER and malignant colon neoplasm: Colon cancer cells (HCT116, HT29) were characterized by relatively high IC50 values for JQ1 and dBET1 (range 3.80–8.95 μM) suggesting that colon cancer is relatively resistant to BET targeting drugs, consistent with previous data [10].